Convertible Note Payable (Details)																		3 Months Ended		6 Months Ended
	Jun. 17, 2024 USD ($) $ / shares shares	May 23, 2024 USD ($)	May 21, 2024 shares	May 20, 2024 USD ($) $ / shares	Apr. 19, 2024 shares	Apr. 17, 2024 USD ($) $ / shares	Apr. 03, 2024 shares	Apr. 02, 2024 USD ($) $ / shares	Feb. 21, 2024 shares	Feb. 16, 2024 USD ($) $ / shares	Feb. 05, 2024 shares	Feb. 01, 2024 USD ($) $ / shares	Jan. 16, 2024 shares	Jan. 11, 2024 USD ($) $ / shares	Apr. 13, 2023 USD ($)	Apr. 19, 2022 $ / shares	Nov. 19, 2021 $ / shares	Jun. 30, 2024 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)
Convertible Note Payable [line Items]
Debt extension fee (in Dollars)															$ 65,639
Note and accrued interest															2.00%
Debt redemptions weighted average price																				82.00%
Number of trading days	10 days			10 days		10 days		10 days		10 days		10 days		10 days	10 days			10 days		10 days
Extension fee		2.00%
Outstanding balance of extension fee (in Dollars)		$ 10,934
Description of interest accrued																				Interest accrues on the outstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as defined in the Note, interest accrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Event of Default, the Investor may accelerate the outstanding balance payable under the Note, which will increase automatically upon such acceleration by 15% or 5%, depending on the nature of the Event of Default.
Redeem of outstanding note (in Dollars)																				$ 500,000
Debt instrument redemption price percentage	82.00%			82.00%		82.00%		82.00%		82.00%		82.00%		82.00%
Note redeemable into shares (in Shares) | shares																				2,003,001
Weighted average price (in Dollars per share) | $ / shares																				$ 0.2049
Debt redemption amount (in Dollars)	$ 150,000			$ 150,000		$ 150,000		$ 150,000		$ 150,000		$ 150,000		$ 150,000
Stock issued during period shares (in Shares) | shares	701,918		590,783		540,735		512,470		408,164		402,685		380,228
Convertible Notes [Member]
Convertible Note Payable [line Items]
Note converted into common stock																70,000	176,229			2,736
Conversion price (in Dollars per share) | $ / shares	$ 0.2137			$ 0.2539		$ 0.2774		$ 0.2927		$ 0.3675		$ 0.3725		$ 0.3945			$ 29.79085	$ 150		$ 150
Debt instrument redemption price percentage																				82.00%
Interest expense (in Dollars)																		$ 19,058	$ 105,545	$ 33,370	$ 151,563
Debt redemption amount (in Dollars)														$ 150,000
Convertible Notes [Member] | China Pharma’s [Member]
Convertible Note Payable [line Items]
Note converted into common stock																				35,000
Minimum [Member]
Convertible Note Payable [line Items]
Debt redemptions weighted average price															85.00%
Redemption amount (in Dollars)		150,000
Maximum [Member]
Convertible Note Payable [line Items]
Debt redemptions weighted average price															82.00%
Redemption amount (in Dollars)		$ 37,182.33
Common Stock [Member] | Convertible Notes [Member] | China Pharma’s [Member]
Convertible Note Payable [line Items]
Conversion price (in Dollars per share) | $ / shares																$ 75